David Goeddel, Ph.D.

David Goeddel, Ph.D.

DirectoratTenaya Therapeutics· In proxies 2023–2025

David Goeddel, Ph.D. sits on 10 public boards.

Boards1

  • Tenaya TherapeuticsDirector · 8 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Tenaya TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -76%
  2. A2 Biotherapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Hexagon Bio, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. NGM, A2 Biotherapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Exonics Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. NGM Biopharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Nura Bio Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Peloton Therapeutics, IncPublic company
    • Director? – PresentNo stock prices for these years
  9. RAPT Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  10. Surrozen, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?